TipRanks
Go Ultimate55% OFF

JCR Pharmaceuticals Co., Ltd. (4552) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Jr-446Mucopolysaccharidosis Iiibphase1AndPhase2Not Yet RecruitingA Phase I/II Trial of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB)May 14, 2026
Jr-446Mucopolysaccharidosis Iii-Bphase1AndPhase2RecruitingAn Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIBJun 28, 2024
Jr-441Mucopolysaccharidosis Iii-Aphase1AndPhase2Active Not RecruitingPhase I/II Study of JR-441 in Patients With Mucopolysaccharidosis Type IIIASep 13, 2023―
Jr-141Mucopolysaccharidosis IiPhase IIIEnrolling By InvitationAn Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in MPS II (Hunter Syndrome) SubjectsOct 06, 2022
Jr-141, Idursulfase, Jr-141 Or IdursulfaseMucopolysaccharidosis IiPhase IIIActive Not RecruitingA Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)Sep 17, 2020―
Jr-171Mucopolysaccharidosis Iphase1AndPhase2CompletedAn Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)Jun 04, 2020―
Jr-171Mucopolysaccharidosis Iphase1AndPhase2CompletedA Study of JR-171 in Patients With Mucopolysaccharidosis IDec 27, 2019―
Jr-141Mucopolysaccharidosis Iiphase2AndPhase3Active Not RecruitingAn Extension Study of JR-141 in Patients With Mucopolysaccharidosis Type IIDec 18, 2019―
Jr-141Mucopolysaccharidosis IiPhase IIActive Not RecruitingAn Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis IISep 27, 2018―
Jr-141Mucopolysaccharidosis IiPhase IICompletedA Study of JR-141 in Patients With Mucopolysaccharidosis II (BR21)Nov 17, 2017―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does JCR Pharmaceuticals Co., Ltd. (JP:4552) have in its pipeline
JCR Pharmaceuticals Co., Ltd. JP:4552 is currently developing the following drugs: Jr-446, Jr-441, Jr-141, Jr-141, Idursulfase, Jr-141 Or Idursulfase, Jr-171. These drug candidates are in various stages of clinical development as the company works toward FDA approval.